skip to main content

Pierce elected to AACR 2024 Class of Fellows of the AACR Academy

Date Visible: 
01/15/2024 - 2:30pm

Media contact: Nicole Fawcett, 734-764-2220 |  Patients may contact Cancer AnswerLine™ 800-865-1125

Lori J. Pierce, M.D., was one of 30 cancer scientists elected to the American Association for Cancer Research (AACR) class of Fellows of the AACR Academy.

The mission of the AACR Academy is to recognize and honor distinguished scientists whose scientific contributions have propelled significant innovation and progress against cancer. Fellows of the AACR Academy serve as a global brain trust of top contributors to cancer science and medicine who help advance the mission of the AACR to prevent and cure all cancers through research, education, communication, collaboration, science policy and advocacy, and funding for cancer research.

Pierce, professor of radiation oncology at Michigan Medicine at vice provost for academic and faculty affairs at the University of Michigan, was elected for “illuminating contributions to establishing radiotherapy in the multimodality treatment of breast cancer, including intensity-modulated radiotherapy for node-positive breast cancer and incorporation of radiosensitizing agents, which have collectively resulted in improved treatment outcomes for breast cancer patients, most notably those harboring BRCA1/2 gene mutations.”

All Fellows are nominated and elected through an annual, multistep peer review process that involves a rigorous assessment of each candidate’s scientific accomplishments in cancer research and cancer-related sciences. Only individuals whose work has had a significant and enduring impact on cancer research are considered for election and induction into the AACR Academy.

“We are very proud to announce the election of 30 new Fellows of the AACR Academy this year. These scientific pioneers from around the globe have fundamentally shaped cancer research through their respective scientific accomplishments,” said Margaret Foti, Ph.D., M.D., chief executive officer of the AACR. “The 2024 class of Fellows includes leaders from many scientific disciplines and areas of study who have collectively contributed to the improvement of the understanding and treatment of cancer. We are thrilled and honored to have them join our 312 existing Fellows and look forward to celebrating their enormous scientific achievements at our upcoming annual meeting.”

All newly elected Fellows of the AACR Academy will be formally recognized during the AACR Annual Meeting 2024 Opening Ceremony at 8 a.m. Pacific Time (11 a.m. Eastern Time) April 7.